Commentary: Efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - Authors' reply

  • C. C. Hu*
  • , R. N. Chien
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)492
Number of pages1
JournalAlimentary Pharmacology and Therapeutics
Volume37
Issue number4
DOIs
StatePublished - 02 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this